Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Pediatric Endocrinology

Do Girls With Turner Syndrome Need Estrogen for Puberty?

At a Glance

Most girls with Turner syndrome need estrogen replacement therapy (ERT) to go through puberty, though up to 30% start naturally. ERT typically begins around age 11 or 12 with an ultra-low dose transdermal patch to induce puberty, protect bone health, and balance growth without stunting height.

Most girls with Turner syndrome will need estrogen replacement therapy (ERT) to go through puberty, because their ovaries usually do not produce enough hormones on their own [1]. However, up to 30% of girls with Turner syndrome will begin puberty naturally [2][3].

Understanding Natural Puberty in Turner Syndrome

Whether a girl goes through puberty spontaneously depends heavily on her specific genetics, known as her karyotype (the unique makeup of her chromosomes). Girls with mosaic Turner syndrome—where only some cells are missing an X chromosome—are much more likely to develop breasts and start their periods naturally compared to girls with the classic 45,X karyotype (where the second X chromosome is completely missing in all cells) [2][4].

Doctors can check hormone levels in the blood, like FSH (follicle-stimulating hormone) and AMH (anti-müllerian hormone), to help predict whether your daughter might start puberty on her own [5][6].

Even for girls who do begin puberty naturally, it is common for the process to stall [7]. The ovaries may stop working prematurely, meaning a girl might grow breast buds but later need estrogen therapy to start her period (menarche) and complete her development [8][7].

The Role of Estrogen Replacement Therapy (ERT)

For the majority of girls who experience early ovarian failure, estrogen replacement therapy (ERT) is a normal, expected step in their care. Pediatric endocrinologists typically recommend starting a very low dose of estrogen around age 11 or 12 [9][10].

The primary goals of ERT are to:

  • Mimic natural puberty: The therapy induces breast development and supports the girl’s psychological readiness for adolescence [1].
  • Protect bone health: Early initiation of estrogen is critical for building strong bone mineral density, which prevents osteoporosis and bone fractures later in life [11][1].
  • Support uterine growth: Estrogen is necessary for the uterus to grow to a normal adult size, which is highly important if she wishes to carry a pregnancy using assisted reproduction in the future [12][11].

Balancing Puberty and Height

Because estrogen causes bone growth plates to fuse, starting estrogen therapy is a delicate balancing act for girls who are also taking growth hormone for short stature. Doctors intentionally start ERT at a very low dose and increase it gradually to allow a girl to continue growing and maximize her final adult height [13][14]. This is also why standard birth control pills are not used to induce puberty—their high estrogen doses can prematurely stunt growth.

What to Expect: A Typical Timeline

To recreate a natural puberty timeline, doctors will slowly increase the estrogen dose over a period of 2 to 3 years [9][15].

  • Age 11–12: Start an ultra-low dose of estrogen to begin breast budding.
  • Ages 12–14: Gradually increase the estrogen dose every 6 months to support continued breast and uterine development.
  • Ages 14–15: Once breakthrough bleeding occurs (early, irregular menstrual spotting) or the uterus has matured, doctors add a second hormone called progestin [15][10]. Progestin protects the uterine lining and establishes regular menstrual periods.

It is important to know that ERT is not just a temporary teenage treatment. Once puberty is complete, an adult dose of ERT is maintained until the typical age of menopause (around age 50) to protect her lifelong bone and heart health [11].

How Estrogen is Taken

Medical guidelines today generally prefer transdermal estrogen—delivered through skin patches or gels—over estrogen pills [15][16]. Patches are typically applied to the skin and changed once or twice a week, while gels are applied daily.

Transdermal estrogen is considered the safest and most natural option because:

  • It is absorbed directly through the skin, avoiding being processed first by the liver [15].
  • It carries a lower risk of blood clots compared to oral estrogen [17].
  • It allows for the ultra-low dosing needed at the very beginning of puberty [18][19].

Common side effects when starting transdermal ERT may include mild skin irritation at the patch site, breast tenderness as they begin to grow, or mild mood fluctuations as her body adjusts to the new hormone levels.

Thinking Ahead: Fertility Preservation

If your daughter is one of the girls who shows signs of natural puberty, this is actually a brief, critical window of time. Because the ovarian reserve (the number of healthy eggs remaining) often drops off rapidly during the teenage years, doctors recommend having a fertility counseling discussion right at the onset of natural puberty [20][21].

Investigating fertility preservation options early—such as freezing eggs or experimental procedures like ovarian tissue cryopreservation—can keep more family-building options open for her future [22][23].

Common questions in this guide

Do all girls with Turner syndrome need estrogen for puberty?
Most girls with Turner syndrome require estrogen replacement therapy to go through puberty. However, up to 30% of girls, especially those with mosaic Turner syndrome, may begin puberty naturally, though the process often stalls without medical support.
When do doctors usually start estrogen therapy for Turner syndrome?
Pediatric endocrinologists typically recommend starting a very low dose of estrogen around age 11 or 12 to mimic a natural puberty timeline. This dose is gradually increased over a period of two to three years.
Why are estrogen patches preferred over pills for inducing puberty?
Transdermal estrogen, such as skin patches or gels, is considered safer and more natural than pills. It is absorbed directly through the skin, avoids processing by the liver, carries a lower risk of blood clots, and allows for the ultra-low dosing needed early on.
How does estrogen therapy affect height in girls with Turner syndrome?
Because estrogen causes bone growth plates to fuse, doctors carefully balance it with growth hormone therapy. Estrogen is started at a very low dose and increased gradually to allow a girl to continue growing and maximize her final adult height.
What should we do if my daughter with Turner syndrome starts puberty naturally?
If natural puberty begins, it represents a brief window where fertility preservation might be possible before her ovarian reserve rapidly drops. It is highly recommended to consult a fertility specialist quickly to explore family-building options for the future.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How will we balance the timing of starting estrogen with her growth hormone therapy to maximize her final adult height?
  2. 2.What specific formulation of transdermal estrogen (patch or gel) do you recommend, and what is the starting dose?
  3. 3.What side effects should we watch for when she starts the estrogen patch or gel, and when should we contact you about them?
  4. 4.How frequently will we check her hormone levels and bone age once she begins estrogen therapy?
  5. 5.If she begins to show signs of natural puberty, how quickly should we schedule a consultation with a fertility preservation specialist?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Does Turner Syndrome Affect Intelligence and Learning?Does Turner Syndrome Cause Hearing Loss & Ear Infections?Why Use Estrogen Patches for Turner Syndrome?How Does the Missing SHOX Gene Cause Short Stature?How to Transition to Adult Care with Turner SyndromeIs Turner Syndrome Inherited or Caused by Parents?Why Do Turner Syndrome Patients Need Kidney Ultrasounds?How to Find Turner Syndrome Support Groups & ResourcesCan You Get Pregnant with Turner Syndrome? Options & RisksWhat Autoimmune Diseases Are Linked to Turner Syndrome?Classic vs. Mosaic Turner Syndrome: What is the Difference?What Is the Turner Syndrome NIPT False Positive Rate?What Is the Average Life Expectancy with Turner Syndrome?When to Start Growth Hormone for Turner SyndromeY-Chromosome in Turner Syndrome: What Is the Risk?Why Do Babies With Turner Syndrome Have Swollen Hands?Why Is Lifelong Heart Monitoring Needed in Turner Syndrome?Why is Pregnancy High-Risk with Turner Syndrome?Why is Turner Syndrome Diagnosis Delayed Until Adolescence?

References

References (23)
  1. 1

    Effects of Hormone Replacement Therapy on Bone Mineral Density in Korean Adults With Turner Syndrome.

    Kim S, Kim H, Lee I, et al.

    Journal of Korean medical science 2024; (39(1)):e9 doi:10.3346/jkms.2024.39.e9.

    PMID: 38193328
  2. 2

    Prediction of Spontaneous Puberty in Turner Syndrome Based on Mid-Childhood Gonadotropin Concentrations, Karyotype, and Ovary Visualization: A Longitudinal Study.

    Hankus M, Soltysik K, Szeliga K, et al.

    Hormone research in paediatrics 2018; (89(2)):90-97 doi:10.1159/000485321.

    PMID: 29275408
  3. 3

    Turner Syndrome Systematic Review: Spontaneous Thelarche and Menarche Stratified by Karyotype.

    Dabrowski E, Jensen R, Johnson EK, et al.

    Hormone research in paediatrics 2019; (92(3)):143-149 doi:10.1159/000502902.

    PMID: 31918426
  4. 4

    Postnatal outcomes of prenatally diagnosed 45,X/46,XX.

    Tokita MJ, Sybert VP

    American journal of medical genetics. Part A 2016; (170A(5)):1196-201 doi:10.1002/ajmg.a.37551.

    PMID: 26789280
  5. 5

    The Cut-Off Value of Serum Anti-Müllerian Hormone Levels for the Diagnosis of Turner Syndrome with Spontaneous Puberty.

    Wang J, Lan T, Dai X, et al.

    International journal of endocrinology 2023; (2023()):6976389 doi:10.1155/2023/6976389.

    PMID: 36844105
  6. 6

    Anti-Müllerian hormone as a biomarker of ovarian function and spontaneous puberty in Turner syndrome: a systematic review.

    Bin-Abbas B, Jabari M

    Frontiers in endocrinology 2025; (16()):1640583 doi:10.3389/fendo.2025.1640583.

    PMID: 41030846
  7. 7

    Evaluation of the usefulness of antymüllerian hormone and inhibin B as markers of ovarian activity in patients with Turner syndrome - preliminary results.

    Ruszała A, Wójcik M, Starzyk J

    Pediatric endocrinology, diabetes, and metabolism 2020; (26(2)):84-88 doi:10.5114/pedm.2020.95622.

    PMID: 32462855
  8. 8

    Fertility preservation and counselling in prepubertal and pubertal girls with Turner syndrome.

    Sage A, Rives N, Levadé R, et al.

    Human reproduction (Oxford, England) 2026; (41(3)):453-467 doi:10.1093/humrep/deaf249.

    PMID: 41535243
  9. 9

    Sex hormone replacement therapy for individuals with Turner syndrome.

    Backeljauw P, Klein K

    American journal of medical genetics. Part C, Seminars in medical genetics 2019; (181(1)):13-17 doi:10.1002/ajmg.c.31685.

    PMID: 30809949
  10. 10

    Estrogen Replacement in Turner Syndrome: Literature Review and Practical Considerations.

    Klein KO, Rosenfield RL, Santen RJ, et al.

    The Journal of clinical endocrinology and metabolism 2018; (103(5)):1790-1803 doi:10.1210/jc.2017-02183.

    PMID: 29438552
  11. 11

    Efficacy of estrogen replacement therapy (ERT) on uterine growth and acquisition of bone mass in patients with Turner syndrome.

    Nakamura T, Tsuburai T, Tokinaga A, et al.

    Endocrine journal 2015; (62(11)):965-70 doi:10.1507/endocrj.EJ15-0172.

    PMID: 26289838
  12. 12

    The Efficacy of Long-Term Estrogen Replacement Therapy in Turner Syndrome Women with Premature Ovarian Insufficiency.

    Son KA, Lee DY, Yoon BK, Choi D

    Journal of pediatric and adolescent gynecology 2019; (32(5)):530-534 doi:10.1016/j.jpag.2019.05.008.

    PMID: 31145987
  13. 13

    Growth During Pubertal Induction in Girls With Turner Syndrome: A Retrospective Cohort Analysis.

    Nicholls J, Harris M, Hughes I, et al.

    The Journal of clinical endocrinology and metabolism 2024; (109(11)):e1992-e2000 doi:10.1210/clinem/dgae071.

    PMID: 38332670
  14. 14

    How Does Turner Syndrome Affect Quality of Life? A Systematic Review.

    Stoynova H, Staynova R, Kafalova D

    Medicina (Kaunas, Lithuania) 2025; (61(9)) doi:10.3390/medicina61091643.

    PMID: 41011033
  15. 15

    Pubertal induction in girls with Turner Syndrome.

    Aversa T, Corica D, Pepe G, et al.

    Minerva endocrinology 2021; (46(4)):469-480 doi:10.23736/S2724-6507.20.03285-X.

    PMID: 33435643
  16. 16

    Bone Health and Pubertal Induction in Turner Syndrome: The Possibility of Earlier Transdermal Lower-Dose Estradiol Therapy for Healthy Bone Density and Quality.

    Hasegawa Y, Ikegawa K, Munenaga T, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2025; (199(2)):107-115 doi:10.1002/ajmg.c.32155.

    PMID: 41121552
  17. 17

    Cardiovascular health and the menopause, metabolic health.

    Anagnostis P, Stevenson JC

    Best practice & research. Clinical endocrinology & metabolism 2024; (38(1)):101781 doi:10.1016/j.beem.2023.101781.

    PMID: 37183085
  18. 18

    Ultra-low-dose estrogen therapy for female hypogonadism.

    Hasegawa Y, Itonaga T, Ikegawa K, et al.

    Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology 2020; (29(2)):49-53 doi:10.1297/cpe.29.49.

    PMID: 32313372
  19. 19

    Pubertal induction in Turner syndrome without gonadal function: A possibility of earlier, lower-dose estrogen therapy.

    Hasegawa Y, Hasegawa T, Satoh M, et al.

    Frontiers in endocrinology 2023; (14()):1051695 doi:10.3389/fendo.2023.1051695.

    PMID: 37056677
  20. 20

    Trends and outcomes of fertility preservation for girls, adolescents and young adults with Turner syndrome: A prospective cohort study.

    Rodriguez-Wallberg KA, Sergouniotis F, Nilsson HP, Lundberg FE

    Frontiers in endocrinology 2023; (14()):1135249 doi:10.3389/fendo.2023.1135249.

    PMID: 36936144
  21. 21

    Transition from pediatrics to adult health care in girls with turner syndrome.

    Sabbadin C, Marin L, Manso J, et al.

    Expert review of endocrinology & metabolism 2024; (19(3)):229-240 doi:10.1080/17446651.2024.2347265.

    PMID: 38664997
  22. 22

    Assessment of folliculogenesis in ovarian tissue from young patients with Turner syndrome using a murine xenograft model.

    Peek R, Nadesapillai S, Thi Nguyen TY, et al.

    Fertility and sterility 2023; (120(2)):371-381 doi:10.1016/j.fertnstert.2023.04.008.

    PMID: 37061159
  23. 23

    Deciding on future fertility: considerations of girls with Turner syndrome and their parents to opt for or against ovarian tissue cryopreservation.

    Nadesapillai S, van der Coelen S, Goebel L, et al.

    Reproductive biomedicine online 2023; (46(6)):1017-1025 doi:10.1016/j.rbmo.2023.02.013.

    PMID: 37062637

This page provides educational information about estrogen replacement therapy and puberty in Turner syndrome. Always consult a pediatric endocrinologist for personalized medical advice regarding your daughter's treatment and growth.

Get notified when new evidence is published on Turner syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.